Moa Technology Series C Funding
Analysis based on 8 articles · First reported Jul 23, 2026 · Last updated Jul 23, 2026
The Series C funding validates Moa Technology's progress in developing novel herbicides to combat weed resistance, potentially strengthening its position in the crop protection market. The investment may positively impact sentiment toward Moa and its partners, though the company is private so direct market impact is limited.
Moa Technology, an agricultural biotechnology company spun out of the University of Oxford in 2017, announced a £22.2 million Series C financing round on July 23, 2026. The round was co-led by Oxford Science Enterprises and Supernova Invest, with participation from new investors Agri Investment Fund, GrainInnovate (managed by Artesian on behalf of the Australia — Grain Research and Development Corporation), Infinity Investment Partners, and Magdalen College Oxford. Existing investors including Lansdowne Partners, Parkwalk Advisors, and Oxford University Innovation also supported the round. The funding will be used to advance Moa's three most advanced herbicide programmes toward commercialisation, build its pipeline of novel mode of action herbicides, and further develop its Moa Amplifiers technology. Moa has already discovered over 80 novel mode of action areas and formed R&D collaborations with Nufarm, Gowan, Certis Belchim, and Corteva Agriscience.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard